跳至主要内容
临床试验/NCT05731453
NCT05731453进行中(未招募)不适用

Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening

Vestre Viken Hospital Trust1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
80
试验地点
1
主要终点
Assessment of breast cancer risk by polygenetic risk score in the study population

研究概览

简要总结

The study aims to evaluate the impact of implementing population-based genetics testing strategy for breast cancer precision prevention using the polygenic risk score and monogenic pathogenic variant (MPV) testing in the Norwegian healthcare setting.

详细描述

The study will recruit women age 40-50 referred for clinical mammography at the Vestre Viken Breast Center, with mammographic density BI-RADS a or d. After informed consent, saliva from the participants will be sampled and tested for polygenetic risk score (PRS) for breast cancer. The participants will be recommended future mammographic screening based on the PRS (standard screening, or more frequent/start at earlier age). The participants family history of cancer will be assessed, and if indicated, the participants will be referred for full genetic counselling/testing. The study will follow the women for 10 years for development of breast cancer as well as compliance to the recommended follow-up.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
40 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women referred for clinical mammography in the Vestre Viken Breast Centre
  • Breast density BI-RADS a or d
  • 40-50 y.o.

排除标准

  • Prior history of breast cancer or premalignant breast disease
  • Prior genetic counselling/testing

结局指标

主要结局

Assessment of breast cancer risk by polygenetic risk score in the study population

时间窗: 10 years

Polygenetic breast cancer risk score (PRS) as a numeric value with 10 percentile, as absolute 10-year breast cancer risk, and as relative risk compared with average women at the same age

次要结局

  • Compliance to individual recommedations for breast cancer screening(10 years)
  • Correlation of polygenetic risk score and breast cancer risk assessed by family history(10 years)
  • Participants´ experience with study participation(10 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验